English
简体中文
Total: £ 56.28
Published Date: 2026-03-24 | Pages: 154 | Tables: 143 | Medical Care
The global Lung Biopsy Systems market was valued at US$ 5720 million in 2025 and is anticipated to reach US$ 10879 million by 2032, at a CAGR of 13.7% from 2026 to 2032.
Lung Biopsy Systems refer to a set of diagnostic equipment used to safely obtain lung tissue or cytology specimens when evaluating suspicious pulmonary lesions or diffuse lung diseases, typically under endoscopic visualization and or imaging based navigation guidance. A typical system combines a bronchoscope or percutaneous sampling instrument, navigation and localization software or a robotic platform, sampling consumables, and supporting energy or processing units. The scope of this research includes transbronchial biopsy forceps and other miniature sampling tools used in conventional or interventional bronchoscopy, cryobiopsy workstations and cryoprobes used for transbronchial cryobiopsy, lung navigation systems that integrate modalities such as electromagnetic navigation and fluoroscopic guidance, and robotic assisted bronchoscopy platforms designed to reach peripheral lung nodules and support tool in lesion confirmation. It may also be extended to include core needle biopsy instruments used for sampling soft tissues such as the lung. This research excludes the surgical service of open or thoracoscopic lung biopsy, laboratory pathology testing and staining consumables, and standalone imaging equipment such as CT or ultrasound systems. Core use cases include lesion characterization after lung cancer screening, histologic confirmation of peripheral small nodules or ground glass nodules, sampling for mediastinal and hilar staging, and tissue acquisition for interstitial lung disease. The value of these systems lies in improving reach and sample yield, reducing repeat punctures and complication risks, lowering cross infection risk and turnaround costs through single use bronchoscopes and consumable kits, and enabling repeatable standardized workflows and recurring consumable revenues supported by software and robotic assistance. Key customers include tertiary hospitals in pulmonology and thoracic surgery, cancer centers and interventional radiology departments, and specialty clinics that run pulmonary nodule programs and day case procedures. Commercial delivery is commonly structured as capital equipment plus single use consumables or service contracts, and can also incorporate subscription based software modules for navigation planning and data management.
Under the expansion of pulmonary nodule screening and rising demand for early diagnosis, Lung Biopsy Systems are evolving from single sampling tools into end to end solutions centered on reach and confirmation. Robotic assisted bronchoscopy platforms combine stable steerability and distal control with navigation modalities such as shape sensing or imaging fusion, enabling more reliable access to peripheral airways and small nodules that are difficult to reach with conventional bronchoscopes. They embed sampling and tool in lesion confirmation into one workflow, improving diagnostic yield and shortening the path from imaging detection to histologic confirmation. In parallel, electromagnetic and fluoroscopic navigation systems provide a lower barrier pathway in cost and deployment, enhancing localization and route planning without replacing existing bronchoscopy infrastructure, allowing more hospitals to adopt minimally invasive sampling for peripheral lesions. As clinicians increasingly prioritize procedural consistency and learning curve, manufacturers are pushing standardized software workflows, training programs, and matched consumable sets, shifting the field from expert experience driven practice toward device and data driven practice. A key clinical pain point is that smaller and more peripheral lesions are harder to stabilize due to scope bending and recoil, leading to failed sampling or repeated attempts. Shape sensing style navigation reduces reliance on fluoroscopy by providing real time catheter shape and location feedback and can link with CT based airway reconstruction to maintain route consistency in complex branching airways. For hospital operators, the value extends beyond per case yield to include room throughput, reduced anesthesia and length of stay, and measurable quality metrics that support multi center collaboration and research.
Sample quality and safety remain the core competitive dimensions, and consumable innovation directly determines achievable tissue volume and complication control. Conventional biopsy forceps are mature and broadly applicable in bronchoscopy, supporting rapid sampling for central airway disease and selected peripheral targets. To meet the need for larger tissue pieces in interstitial lung disease and peripheral nodules, transbronchial cryobiopsy leverages cryoadhesion to preserve tissue architecture, creating a high value consumable chain built around cryosurgical workstations and single use or reusable cryoprobes. For the percutaneous route, core needle biopsy instruments can provide standardized cylindrical tissue specimens in soft tissues such as the lung, enabling fast confirmation under imaging guidance, while requiring robust pathway planning and complication management. Single use bronchoscopes and compatible sampling instruments are becoming an important complement, reducing cross infection risk and enabling more stable equipment availability and predictable costs in high throughput units. On the consumables side, manufacturers are improving jaw geometry, opening angle, sheath coating straightness, and rotatable handle structures to increase sampling efficiency and reduce mucosal trauma. Some products use color coding and specification systems to differentiate anatomical applications and working channel compatibility, supporting inventory management and nursing setup. Cryobiopsy emphasizes repeatable freeze timing and probe diameter selection, and protective oversheaths can protect scope channels during extraction and reduce thermal damage risk. For percutaneous biopsy, combinations of automatic or semi automatic firing mechanisms with coaxial needle systems help maintain the pathway while enabling multiple passes, increasing diagnostic information per procedure. With accumulating guidelines and evidence, hospitals are more likely to adopt a stratified approach by lesion type, driving coexistence of multiple techniques rather than one technology fully replacing another.
Commercially, Lung Biopsy Systems typically grow through a hybrid model of capital platforms plus recurring consumables. Navigation systems and robotic platforms drive upfront capital purchases, while high frequency consumables such as biopsy forceps, needles, and cryoprobes sustain recurring revenue and incentivize ecosystem optimization. Future growth is expected from three areas, deeper penetration of AI and software in pre procedure planning, intra procedure correction, and reporting and data management, higher sampling volumes driven by the expanding screened population and rising peripheral small nodule detection, and procurement mix shifts driven by the growing adoption of single use endoscopes and consumable kits. From a policy and compliance perspective, tighter requirements on quality systems and infection control will further encourage the use of single use devices and traceable consumables. In manufacturing geography, the US and Europe retain advantages in robotic systems and navigation algorithm platforms, while China, Japan, and Korea are strengthening supply capability in single use endoscopy and endoscopic consumables. In sales geography, North America and Europe are likely to continue leading high end platform installations due to mature screening and interventional pulmonology pathways, while Asia Pacific is positioned as a key incremental market supported by hospital capacity expansion and domestic substitution. In tendering and reimbursement environments, more institutions are incorporating Lung Biopsy Systems into early detection and treatment pathways, building closed loops from screening imaging to follow up and tissue confirmation. Manufacturers reduce post installation friction through interoperability with bronchoscopy towers, fluoroscopy and ultrasound equipment, and through training and service offerings. On the supply chain side, capabilities in key components such as high precision sensors and single use insertion tubes will shape cost curves and may improve accessibility in lower tier markets as scale increases. Competition may evolve along two parallel routes, a high end integrated route centered on robotics and navigation platforms, and a high throughput route centered on single use endoscopy plus standardized consumable bundles, with both developing in parallel across regions and hospital tiers.
This report delivers a comprehensive overview of the global Lung Biopsy Systems market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Lung Biopsy Systems. The Lung Biopsy Systems market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Lung Biopsy Systems market comprehensively. Regional market sizes by Type, by Application, by Access Route, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Lung Biopsy Systems manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Intuitive Surgical, Inc.
Johnson & Johnson MedTech (Ethicon)
Medtronic plc
Olympus Corporation
ERBE Elektromedizin GmbH
Ambu A/S
Boston Scientific Corporation
Cook Medical LLC
KARL STORZ SE & Co. KG
Technowood Co., Ltd.
Sumitomo Bakelite Co., Ltd.
HOYA Corporation (PENTAX Medical)
FINEMEDIX CO., LTD.
Upex-Med Corp.
Medcare Medical (Medcare Medical Co., Ltd.)
Argon Medical Devices, Inc.
Becton, Dickinson and Company (BD)
Hunan Vathin Medical Instrument Co., Ltd.
Shanghai Aohua Photoelectricity Endoscope Co., Ltd.
SonoScape Medical Corp.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Jiangsu Vedkang Medical Science and Technology Co., Ltd.
Zhuji Peng Tian Medical Instrument Co.,Ltd
Segment by Type
Needle Biopsy
Thoracoscopic Biopsy
Transbronchial Biopsy
Segment by Access Route
Bronchoscopic
Percutaneous
Segment by Navigation Modality
No Navigation
Electromagnetic Navigation
Robotic Navigation
Shape Sensing
Segment by Application
Hospitals
Cancer Research Centers
Specialty Clinics
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Access Route, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Lung Biopsy Systems companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Biopsy Systems Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Needle Biopsy
1.2.3 Thoracoscopic Biopsy
1.2.4 Transbronchial Biopsy
1.3 Market by Access Route
1.3.1 Global Lung Biopsy Systems Market Size Growth Rate by Access Route: 2021 vs 2025 vs 2032
1.3.2 Bronchoscopic
1.3.3 Percutaneous
1.4 Market by Navigation Modality
1.4.1 Global Lung Biopsy Systems Market Size Growth Rate by Navigation Modality: 2021 vs 2025 vs 2032
1.4.2 No Navigation
1.4.3 Electromagnetic Navigation
1.4.4 Robotic Navigation
1.4.5 Shape Sensing
1.5 Market by Application
1.5.1 Global Lung Biopsy Systems Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Hospitals
1.5.3 Cancer Research Centers
1.5.4 Specialty Clinics
1.5.5 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Lung Biopsy Systems Market Perspective (2021–2032)
2.2 Global Lung Biopsy Systems Growth Trends by Region
2.2.1 Global Lung Biopsy Systems Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Lung Biopsy Systems Historic Market Size by Region (2021–2026)
2.2.3 Lung Biopsy Systems Forecasted Market Size by Region (2027–2032)
2.3 Lung Biopsy Systems Market Dynamics
2.3.1 Lung Biopsy Systems Industry Trends
2.3.2 Lung Biopsy Systems Market Drivers
2.3.3 Lung Biopsy Systems Market Challenges
2.3.4 Lung Biopsy Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lung Biopsy Systems Players by Revenue
3.1.1 Global Top Lung Biopsy Systems Players by Revenue (2021–2026)
3.1.2 Global Lung Biopsy Systems Revenue Market Share by Players (2021–2026)
3.2 Global Top Lung Biopsy Systems Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Lung Biopsy Systems Revenue
3.4 Global Lung Biopsy Systems Market Concentration Ratio
3.4.1 Global Lung Biopsy Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Biopsy Systems Revenue in 2025
3.5 Global Key Players of Lung Biopsy Systems Head Offices and Areas Served
3.6 Global Key Players of Lung Biopsy Systems, Products and Applications
3.7 Global Key Players of Lung Biopsy Systems, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Lung Biopsy Systems Breakdown Data by Type
4.1 Global Lung Biopsy Systems Historic Market Size by Type (2021–2026)
4.2 Global Lung Biopsy Systems Forecasted Market Size by Type (2027–2032)
5 Lung Biopsy Systems Breakdown Data by Application
5.1 Global Lung Biopsy Systems Historic Market Size by Application (2021–2026)
5.2 Global Lung Biopsy Systems Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Lung Biopsy Systems Market Size (2021–2032)
6.2 North America Lung Biopsy Systems Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Lung Biopsy Systems Market Size by Country (2021–2026)
6.4 North America Lung Biopsy Systems Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lung Biopsy Systems Market Size (2021–2032)
7.2 Europe Lung Biopsy Systems Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Lung Biopsy Systems Market Size by Country (2021–2026)
7.4 Europe Lung Biopsy Systems Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Lung Biopsy Systems Market Size (2021–2032)
8.2 Asia-Pacific Lung Biopsy Systems Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Lung Biopsy Systems Market Size by Region (2021–2026)
8.4 Asia-Pacific Lung Biopsy Systems Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Lung Biopsy Systems Market Size (2021–2032)
9.2 Latin America Lung Biopsy Systems Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Lung Biopsy Systems Market Size by Country (2021–2026)
9.4 Latin America Lung Biopsy Systems Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lung Biopsy Systems Market Size (2021–2032)
10.2 Middle East & Africa Lung Biopsy Systems Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Lung Biopsy Systems Market Size by Country (2021–2026)
10.4 Middle East & Africa Lung Biopsy Systems Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Intuitive Surgical, Inc.
11.1.1 Intuitive Surgical, Inc. Company Details
11.1.2 Intuitive Surgical, Inc. Business Overview
11.1.3 Intuitive Surgical, Inc. Lung Biopsy Systems Introduction
11.1.4 Intuitive Surgical, Inc. Revenue in Lung Biopsy Systems Business (2021–2026)
11.1.5 Intuitive Surgical, Inc. Recent Development
11.2 Johnson & Johnson MedTech (Ethicon)
11.2.1 Johnson & Johnson MedTech (Ethicon) Company Details
11.2.2 Johnson & Johnson MedTech (Ethicon) Business Overview
11.2.3 Johnson & Johnson MedTech (Ethicon) Lung Biopsy Systems Introduction
11.2.4 Johnson & Johnson MedTech (Ethicon) Revenue in Lung Biopsy Systems Business (2021–2026)
11.2.5 Johnson & Johnson MedTech (Ethicon) Recent Development
11.3 Medtronic plc
11.3.1 Medtronic plc Company Details
11.3.2 Medtronic plc Business Overview
11.3.3 Medtronic plc Lung Biopsy Systems Introduction
11.3.4 Medtronic plc Revenue in Lung Biopsy Systems Business (2021–2026)
11.3.5 Medtronic plc Recent Development
11.4 Olympus Corporation
11.4.1 Olympus Corporation Company Details
11.4.2 Olympus Corporation Business Overview
11.4.3 Olympus Corporation Lung Biopsy Systems Introduction
11.4.4 Olympus Corporation Revenue in Lung Biopsy Systems Business (2021–2026)
11.4.5 Olympus Corporation Recent Development
11.5 ERBE Elektromedizin GmbH
11.5.1 ERBE Elektromedizin GmbH Company Details
11.5.2 ERBE Elektromedizin GmbH Business Overview
11.5.3 ERBE Elektromedizin GmbH Lung Biopsy Systems Introduction
11.5.4 ERBE Elektromedizin GmbH Revenue in Lung Biopsy Systems Business (2021–2026)
11.5.5 ERBE Elektromedizin GmbH Recent Development
11.6 Ambu A/S
11.6.1 Ambu A/S Company Details
11.6.2 Ambu A/S Business Overview
11.6.3 Ambu A/S Lung Biopsy Systems Introduction
11.6.4 Ambu A/S Revenue in Lung Biopsy Systems Business (2021–2026)
11.6.5 Ambu A/S Recent Development
11.7 Boston Scientific Corporation
11.7.1 Boston Scientific Corporation Company Details
11.7.2 Boston Scientific Corporation Business Overview
11.7.3 Boston Scientific Corporation Lung Biopsy Systems Introduction
11.7.4 Boston Scientific Corporation Revenue in Lung Biopsy Systems Business (2021–2026)
11.7.5 Boston Scientific Corporation Recent Development
11.8 Cook Medical LLC
11.8.1 Cook Medical LLC Company Details
11.8.2 Cook Medical LLC Business Overview
11.8.3 Cook Medical LLC Lung Biopsy Systems Introduction
11.8.4 Cook Medical LLC Revenue in Lung Biopsy Systems Business (2021–2026)
11.8.5 Cook Medical LLC Recent Development
11.9 KARL STORZ SE & Co. KG
11.9.1 KARL STORZ SE & Co. KG Company Details
11.9.2 KARL STORZ SE & Co. KG Business Overview
11.9.3 KARL STORZ SE & Co. KG Lung Biopsy Systems Introduction
11.9.4 KARL STORZ SE & Co. KG Revenue in Lung Biopsy Systems Business (2021–2026)
11.9.5 KARL STORZ SE & Co. KG Recent Development
11.10 Technowood Co., Ltd.
11.10.1 Technowood Co., Ltd. Company Details
11.10.2 Technowood Co., Ltd. Business Overview
11.10.3 Technowood Co., Ltd. Lung Biopsy Systems Introduction
11.10.4 Technowood Co., Ltd. Revenue in Lung Biopsy Systems Business (2021–2026)
11.10.5 Technowood Co., Ltd. Recent Development
11.11 Sumitomo Bakelite Co., Ltd.
11.11.1 Sumitomo Bakelite Co., Ltd. Company Details
11.11.2 Sumitomo Bakelite Co., Ltd. Business Overview
11.11.3 Sumitomo Bakelite Co., Ltd. Lung Biopsy Systems Introduction
11.11.4 Sumitomo Bakelite Co., Ltd. Revenue in Lung Biopsy Systems Business (2021–2026)
11.11.5 Sumitomo Bakelite Co., Ltd. Recent Development
11.12 HOYA Corporation (PENTAX Medical)
11.12.1 HOYA Corporation (PENTAX Medical) Company Details
11.12.2 HOYA Corporation (PENTAX Medical) Business Overview
11.12.3 HOYA Corporation (PENTAX Medical) Lung Biopsy Systems Introduction
11.12.4 HOYA Corporation (PENTAX Medical) Revenue in Lung Biopsy Systems Business (2021–2026)
11.12.5 HOYA Corporation (PENTAX Medical) Recent Development
11.13 FINEMEDIX CO., LTD.
11.13.1 FINEMEDIX CO., LTD. Company Details
11.13.2 FINEMEDIX CO., LTD. Business Overview
11.13.3 FINEMEDIX CO., LTD. Lung Biopsy Systems Introduction
11.13.4 FINEMEDIX CO., LTD. Revenue in Lung Biopsy Systems Business (2021–2026)
11.13.5 FINEMEDIX CO., LTD. Recent Development
11.14 Upex-Med Corp.
11.14.1 Upex-Med Corp. Company Details
11.14.2 Upex-Med Corp. Business Overview
11.14.3 Upex-Med Corp. Lung Biopsy Systems Introduction
11.14.4 Upex-Med Corp. Revenue in Lung Biopsy Systems Business (2021–2026)
11.14.5 Upex-Med Corp. Recent Development
11.15 Medcare Medical (Medcare Medical Co., Ltd.)
11.15.1 Medcare Medical (Medcare Medical Co., Ltd.) Company Details
11.15.2 Medcare Medical (Medcare Medical Co., Ltd.) Business Overview
11.15.3 Medcare Medical (Medcare Medical Co., Ltd.) Lung Biopsy Systems Introduction
11.15.4 Medcare Medical (Medcare Medical Co., Ltd.) Revenue in Lung Biopsy Systems Business (2021–2026)
11.15.5 Medcare Medical (Medcare Medical Co., Ltd.) Recent Development
11.16 Argon Medical Devices, Inc.
11.16.1 Argon Medical Devices, Inc. Company Details
11.16.2 Argon Medical Devices, Inc. Business Overview
11.16.3 Argon Medical Devices, Inc. Lung Biopsy Systems Introduction
11.16.4 Argon Medical Devices, Inc. Revenue in Lung Biopsy Systems Business (2021–2026)
11.16.5 Argon Medical Devices, Inc. Recent Development
11.17 Becton, Dickinson and Company (BD)
11.17.1 Becton, Dickinson and Company (BD) Company Details
11.17.2 Becton, Dickinson and Company (BD) Business Overview
11.17.3 Becton, Dickinson and Company (BD) Lung Biopsy Systems Introduction
11.17.4 Becton, Dickinson and Company (BD) Revenue in Lung Biopsy Systems Business (2021–2026)
11.17.5 Becton, Dickinson and Company (BD) Recent Development
11.18 Hunan Vathin Medical Instrument Co., Ltd.
11.18.1 Hunan Vathin Medical Instrument Co., Ltd. Company Details
11.18.2 Hunan Vathin Medical Instrument Co., Ltd. Business Overview
11.18.3 Hunan Vathin Medical Instrument Co., Ltd. Lung Biopsy Systems Introduction
11.18.4 Hunan Vathin Medical Instrument Co., Ltd. Revenue in Lung Biopsy Systems Business (2021–2026)
11.18.5 Hunan Vathin Medical Instrument Co., Ltd. Recent Development
11.19 Shanghai Aohua Photoelectricity Endoscope Co., Ltd.
11.19.1 Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Company Details
11.19.2 Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Business Overview
11.19.3 Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Lung Biopsy Systems Introduction
11.19.4 Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Revenue in Lung Biopsy Systems Business (2021–2026)
11.19.5 Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Recent Development
11.20 SonoScape Medical Corp.
11.20.1 SonoScape Medical Corp. Company Details
11.20.2 SonoScape Medical Corp. Business Overview
11.20.3 SonoScape Medical Corp. Lung Biopsy Systems Introduction
11.20.4 SonoScape Medical Corp. Revenue in Lung Biopsy Systems Business (2021–2026)
11.20.5 SonoScape Medical Corp. Recent Development
11.21 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
11.21.1 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Company Details
11.21.2 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Business Overview
11.21.3 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Lung Biopsy Systems Introduction
11.21.4 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Revenue in Lung Biopsy Systems Business (2021–2026)
11.21.5 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Recent Development
11.22 Jiangsu Vedkang Medical Science and Technology Co., Ltd.
11.22.1 Jiangsu Vedkang Medical Science and Technology Co., Ltd. Company Details
11.22.2 Jiangsu Vedkang Medical Science and Technology Co., Ltd. Business Overview
11.22.3 Jiangsu Vedkang Medical Science and Technology Co., Ltd. Lung Biopsy Systems Introduction
11.22.4 Jiangsu Vedkang Medical Science and Technology Co., Ltd. Revenue in Lung Biopsy Systems Business (2021–2026)
11.22.5 Jiangsu Vedkang Medical Science and Technology Co., Ltd. Recent Development
11.23 Zhuji Peng Tian Medical Instrument Co.,Ltd
11.23.1 Zhuji Peng Tian Medical Instrument Co.,Ltd Company Details
11.23.2 Zhuji Peng Tian Medical Instrument Co.,Ltd Business Overview
11.23.3 Zhuji Peng Tian Medical Instrument Co.,Ltd Lung Biopsy Systems Introduction
11.23.4 Zhuji Peng Tian Medical Instrument Co.,Ltd Revenue in Lung Biopsy Systems Business (2021–2026)
11.23.5 Zhuji Peng Tian Medical Instrument Co.,Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Lung Biopsy Systems Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Needle Biopsy
Table 3. Key Players of Thoracoscopic Biopsy
Table 4. Key Players of Transbronchial Biopsy
Table 5. Global Lung Biopsy Systems Market Size Growth Rate by Access Route (US$ Million): 2021 vs 2025 vs 2032
Table 6. Key Players of Bronchoscopic
Table 7. Key Players of Percutaneous
Table 8. Global Lung Biopsy Systems Market Size Growth Rate by Navigation Modality (US$ Million): 2021 vs 2025 vs 2032
Table 9. Key Players of No Navigation
Table 10. Key Players of Electromagnetic Navigation
Table 11. Key Players of Robotic Navigation
Table 12. Key Players of Shape Sensing
Table 13. Global Lung Biopsy Systems Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 14. Global Lung Biopsy Systems Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 15. Global Lung Biopsy Systems Market Size by Region (US$ Million), 2021–2026
Table 16. Global Lung Biopsy Systems Market Share by Region (2021–2026)
Table 17. Global Lung Biopsy Systems Forecasted Market Size by Region (US$ Million), 2027–2032
Table 18. Global Lung Biopsy Systems Market Share by Region (2027–2032)
Table 19. Lung Biopsy Systems Market Trends
Table 20. Lung Biopsy Systems Market Drivers
Table 21. Lung Biopsy Systems Market Challenges
Table 22. Lung Biopsy Systems Market Restraints
Table 23. Global Lung Biopsy Systems Revenue by Players (US$ Million), 2021–2026
Table 24. Global Lung Biopsy Systems Market Share by Players (2021–2026)
Table 25. Global Top Lung Biopsy Systems Players by Tier (Tier 1, Tier 2, and Tier 3), based on Lung Biopsy Systems Revenue, 2025
Table 26. Ranking of Global Top Lung Biopsy Systems Companies by Revenue (US$ Million) in 2025
Table 27. Global 5 Largest Players Market Share by Lung Biopsy Systems Revenue (CR5 and HHI), 2021–2026
Table 28. Global Key Players of Lung Biopsy Systems, Headquarters and Area Served
Table 29. Global Key Players of Lung Biopsy Systems, Products and Applications
Table 30. Global Key Players of Lung Biopsy Systems, Date of General Availability (GA)
Table 31. Mergers and Acquisitions, Expansion Plans
Table 32. Global Lung Biopsy Systems Market Size by Type (US$ Million), 2021–2026
Table 33. Global Lung Biopsy Systems Revenue Market Share by Type (2021–2026)
Table 34. Global Lung Biopsy Systems Forecasted Market Size by Type (US$ Million), 2027–2032
Table 35. Global Lung Biopsy Systems Revenue Market Share by Type (2027–2032)
Table 36. Global Lung Biopsy Systems Market Size by Application (US$ Million), 2021–2026
Table 37. Global Lung Biopsy Systems Revenue Market Share by Application (2021–2026)
Table 38. Global Lung Biopsy Systems Forecasted Market Size by Application (US$ Million), 2027–2032
Table 39. Global Lung Biopsy Systems Revenue Market Share by Application (2027–2032)
Table 40. North America Lung Biopsy Systems Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. North America Lung Biopsy Systems Market Size by Country (US$ Million), 2021–2026
Table 42. North America Lung Biopsy Systems Market Size by Country (US$ Million), 2027–2032
Table 43. Europe Lung Biopsy Systems Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Europe Lung Biopsy Systems Market Size by Country (US$ Million), 2021–2026
Table 45. Europe Lung Biopsy Systems Market Size by Country (US$ Million), 2027–2032
Table 46. Asia-Pacific Lung Biopsy Systems Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 47. Asia-Pacific Lung Biopsy Systems Market Size by Region (US$ Million), 2021–2026
Table 48. Asia-Pacific Lung Biopsy Systems Market Size by Region (US$ Million), 2027–2032
Table 49. Latin America Lung Biopsy Systems Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 50. Latin America Lung Biopsy Systems Market Size by Country (US$ Million), 2021–2026
Table 51. Latin America Lung Biopsy Systems Market Size by Country (US$ Million), 2027–2032
Table 52. Middle East & Africa Lung Biopsy Systems Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 53. Middle East & Africa Lung Biopsy Systems Market Size by Country (US$ Million), 2021–2026
Table 54. Middle East & Africa Lung Biopsy Systems Market Size by Country (US$ Million), 2027–2032
Table 55. Intuitive Surgical, Inc. Company Details
Table 56. Intuitive Surgical, Inc. Business Overview
Table 57. Intuitive Surgical, Inc. Lung Biopsy Systems Product
Table 58. Intuitive Surgical, Inc. Revenue in Lung Biopsy Systems Business (US$ Million), 2021–2026
Table 59. Intuitive Surgical, Inc. Recent Development
Table 60. Johnson & Johnson MedTech (Ethicon) Company Details
Table 61. Johnson & Johnson MedTech (Ethicon) Business Overview
Table 62. Johnson & Johnson MedTech (Ethicon) Lung Biopsy Systems Product
Table 63. Johnson & Johnson MedTech (Ethicon) Revenue in Lung Biopsy Systems Business (US$ Million), 2021–2026
Table 64. Johnson & Johnson MedTech (Ethicon) Recent Development
Table 65. Medtronic plc Company Details
Table 66. Medtronic plc Business Overview
Table 67. Medtronic plc Lung Biopsy Systems Product
Table 68. Medtronic plc Revenue in Lung Biopsy Systems Business (US$ Million), 2021–2026
Table 69. Medtronic plc Recent Development
Table 70. Olympus Corporation Company Details
Table 71. Olympus Corporation Business Overview
Table 72. Olympus Corporation Lung Biopsy Systems Product
Table 73. Olympus Corporation Revenue in Lung Biopsy Systems Business (US$ Million), 2021–2026
Table 74. Olympus Corporation Recent Development
Table 75. ERBE Elektromedizin GmbH Company Details
Table 76. ERBE Elektromedizin GmbH Business Overview
Table 77. ERBE Elektromedizin GmbH Lung Biopsy Systems Product
Table 78. ERBE Elektromedizin GmbH Revenue in Lung Biopsy Systems Business (US$ Million), 2021–2026
Table 79. ERBE Elektromedizin GmbH Recent Development
Table 80. Ambu A/S Company Details
Table 81. Ambu A/S Business Overview
Table 82. Ambu A/S Lung Biopsy Systems Product
Table 83. Ambu A/S Revenue in Lung Biopsy Systems Business (US$ Million), 2021–2026
Table 84. Ambu A/S Recent Development
Table 85. Boston Scientific Corporation Company Details
Table 86. Boston Scientific Corporation Business Overview
Table 87. Boston Scientific Corporation Lung Biopsy Systems Product
Table 88. Boston Scientific Corporation Revenue in Lung Biopsy Systems Business (US$ Million), 2021–2026
Table 89. Boston Scientific Corporation Recent Development
Table 90. Cook Medical LLC Company Details
Table 91. Cook Medical LLC Business Overview
Table 92. Cook Medical LLC Lung Biopsy Systems Product
Table 93. Cook Medical LLC Revenue in Lung Biopsy Systems Business (US$ Million), 2021–2026
Table 94. Cook Medical LLC Recent Development
Table 95. KARL STORZ SE & Co. KG Company Details
Table 96. KARL STORZ SE & Co. KG Business Overview
Table 97. KARL STORZ SE & Co. KG Lung Biopsy Systems Product
Table 98. KARL STORZ SE & Co. KG Revenue in Lung Biopsy Systems Business (US$ Million), 2021–2026
Table 99. KARL STORZ SE & Co. KG Recent Development
Table 100. Technowood Co., Ltd. Company Details
Table 101. Technowood Co., Ltd. Business Overview
Table 102. Technowood Co., Ltd. Lung Biopsy Systems Product
Table 103. Technowood Co., Ltd. Revenue in Lung Biopsy Systems Business (US$ Million), 2021–2026
Table 104. Technowood Co., Ltd. Recent Development
Table 105. Sumitomo Bakelite Co., Ltd. Company Details
Table 106. Sumitomo Bakelite Co., Ltd. Business Overview
Table 107. Sumitomo Bakelite Co., Ltd. Lung Biopsy Systems Product
Table 108. Sumitomo Bakelite Co., Ltd. Revenue in Lung Biopsy Systems Business (US$ Million), 2021–2026
Table 109. Sumitomo Bakelite Co., Ltd. Recent Development
Table 110. HOYA Corporation (PENTAX Medical) Company Details
Table 111. HOYA Corporation (PENTAX Medical) Business Overview
Table 112. HOYA Corporation (PENTAX Medical) Lung Biopsy Systems Product
Table 113. HOYA Corporation (PENTAX Medical) Revenue in Lung Biopsy Systems Business (US$ Million), 2021–2026
Table 114. HOYA Corporation (PENTAX Medical) Recent Development
Table 115. FINEMEDIX CO., LTD. Company Details
Table 116. FINEMEDIX CO., LTD. Business Overview
Table 117. FINEMEDIX CO., LTD. Lung Biopsy Systems Product
Table 118. FINEMEDIX CO., LTD. Revenue in Lung Biopsy Systems Business (US$ Million), 2021–2026
Table 119. FINEMEDIX CO., LTD. Recent Development
Table 120. Upex-Med Corp. Company Details
Table 121. Upex-Med Corp. Business Overview
Table 122. Upex-Med Corp. Lung Biopsy Systems Product
Table 123. Upex-Med Corp. Revenue in Lung Biopsy Systems Business (US$ Million), 2021–2026
Table 124. Upex-Med Corp. Recent Development
Table 125. Medcare Medical (Medcare Medical Co., Ltd.) Company Details
Table 126. Medcare Medical (Medcare Medical Co., Ltd.) Business Overview
Table 127. Medcare Medical (Medcare Medical Co., Ltd.) Lung Biopsy Systems Product
Table 128. Medcare Medical (Medcare Medical Co., Ltd.) Revenue in Lung Biopsy Systems Business (US$ Million), 2021–2026
Table 129. Medcare Medical (Medcare Medical Co., Ltd.) Recent Development
Table 130. Argon Medical Devices, Inc. Company Details
Table 131. Argon Medical Devices, Inc. Business Overview
Table 132. Argon Medical Devices, Inc. Lung Biopsy Systems Product
Table 133. Argon Medical Devices, Inc. Revenue in Lung Biopsy Systems Business (US$ Million), 2021–2026
Table 134. Argon Medical Devices, Inc. Recent Development
Table 135. Becton, Dickinson and Company (BD) Company Details
Table 136. Becton, Dickinson and Company (BD) Business Overview
Table 137. Becton, Dickinson and Company (BD) Lung Biopsy Systems Product
Table 138. Becton, Dickinson and Company (BD) Revenue in Lung Biopsy Systems Business (US$ Million), 2021–2026
Table 139. Becton, Dickinson and Company (BD) Recent Development
Table 140. Hunan Vathin Medical Instrument Co., Ltd. Company Details
Table 141. Hunan Vathin Medical Instrument Co., Ltd. Business Overview
Table 142. Hunan Vathin Medical Instrument Co., Ltd. Lung Biopsy Systems Product
Table 143. Hunan Vathin Medical Instrument Co., Ltd. Revenue in Lung Biopsy Systems Business (US$ Million), 2021–2026
Table 144. Hunan Vathin Medical Instrument Co., Ltd. Recent Development
Table 145. Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Company Details
Table 146. Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Business Overview
Table 147. Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Lung Biopsy Systems Product
Table 148. Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Revenue in Lung Biopsy Systems Business (US$ Million), 2021–2026
Table 149. Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Recent Development
Table 150. SonoScape Medical Corp. Company Details
Table 151. SonoScape Medical Corp. Business Overview
Table 152. SonoScape Medical Corp. Lung Biopsy Systems Product
Table 153. SonoScape Medical Corp. Revenue in Lung Biopsy Systems Business (US$ Million), 2021–2026
Table 154. SonoScape Medical Corp. Recent Development
Table 155. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Company Details
Table 156. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Business Overview
Table 157. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Lung Biopsy Systems Product
Table 158. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Revenue in Lung Biopsy Systems Business (US$ Million), 2021–2026
Table 159. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Recent Development
Table 160. Jiangsu Vedkang Medical Science and Technology Co., Ltd. Company Details
Table 161. Jiangsu Vedkang Medical Science and Technology Co., Ltd. Business Overview
Table 162. Jiangsu Vedkang Medical Science and Technology Co., Ltd. Lung Biopsy Systems Product
Table 163. Jiangsu Vedkang Medical Science and Technology Co., Ltd. Revenue in Lung Biopsy Systems Business (US$ Million), 2021–2026
Table 164. Jiangsu Vedkang Medical Science and Technology Co., Ltd. Recent Development
Table 165. Zhuji Peng Tian Medical Instrument Co.,Ltd Company Details
Table 166. Zhuji Peng Tian Medical Instrument Co.,Ltd Business Overview
Table 167. Zhuji Peng Tian Medical Instrument Co.,Ltd Lung Biopsy Systems Product
Table 168. Zhuji Peng Tian Medical Instrument Co.,Ltd Revenue in Lung Biopsy Systems Business (US$ Million), 2021–2026
Table 169. Zhuji Peng Tian Medical Instrument Co.,Ltd Recent Development
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
Table 173. Authors List of This Report
List of Figures
Figure 1. Lung Biopsy Systems Picture
Figure 2. Global Lung Biopsy Systems Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Lung Biopsy Systems Market Share by Type: 2025 vs 2032
Figure 4. Needle Biopsy Features
Figure 5. Thoracoscopic Biopsy Features
Figure 6. Transbronchial Biopsy Features
Figure 7. Global Lung Biopsy Systems Market Size Comparison by Access Route (US$ Million), 2021–2032
Figure 8. Bronchoscopic Features
Figure 9. Percutaneous Features
Figure 10. Global Lung Biopsy Systems Market Size Comparison by Navigation Modality (US$ Million), 2021–2032
Figure 11. No Navigation Features
Figure 12. Electromagnetic Navigation Features
Figure 13. Robotic Navigation Features
Figure 14. Shape Sensing Features
Figure 15. Global Lung Biopsy Systems Market Size by Application (US$ Million), 2021–2032
Figure 16. Global Lung Biopsy Systems Market Share by Application: 2025 vs 2032
Figure 17. Hospitals Case Studies
Figure 18. Cancer Research Centers Case Studies
Figure 19. Specialty Clinics Case Studies
Figure 20. Others Case Studies
Figure 21. Lung Biopsy Systems Report Years Considered
Figure 22. Global Lung Biopsy Systems Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 23. Global Lung Biopsy Systems Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 24. Global Lung Biopsy Systems Market Share by Region: 2025 vs 2032
Figure 25. Global Lung Biopsy Systems Market Share by Players in 2025
Figure 26. Global Lung Biopsy Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 27. The Top 10 and 5 Players Market Share by Lung Biopsy Systems Revenue in 2025
Figure 28. North America Lung Biopsy Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. North America Lung Biopsy Systems Market Share by Country (2021–2032)
Figure 30. United States Lung Biopsy Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Canada Lung Biopsy Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Europe Lung Biopsy Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Europe Lung Biopsy Systems Market Share by Country (2021–2032)
Figure 34. Germany Lung Biopsy Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. France Lung Biopsy Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. U.K. Lung Biopsy Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Italy Lung Biopsy Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Russia Lung Biopsy Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Ireland Lung Biopsy Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Asia-Pacific Lung Biopsy Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Asia-Pacific Lung Biopsy Systems Market Share by Region (2021–2032)
Figure 42. China Lung Biopsy Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Japan Lung Biopsy Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. South Korea Lung Biopsy Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Southeast Asia Lung Biopsy Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. India Lung Biopsy Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Australia & New Zealand Lung Biopsy Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Latin America Lung Biopsy Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Latin America Lung Biopsy Systems Market Share by Country (2021–2032)
Figure 50. Mexico Lung Biopsy Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Brazil Lung Biopsy Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. Middle East & Africa Lung Biopsy Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 53. Middle East & Africa Lung Biopsy Systems Market Share by Country (2021–2032)
Figure 54. Israel Lung Biopsy Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 55. Saudi Arabia Lung Biopsy Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 56. UAE Lung Biopsy Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 57. Intuitive Surgical, Inc. Revenue Growth Rate in Lung Biopsy Systems Business (2021–2026)
Figure 58. Johnson & Johnson MedTech (Ethicon) Revenue Growth Rate in Lung Biopsy Systems Business (2021–2026)
Figure 59. Medtronic plc Revenue Growth Rate in Lung Biopsy Systems Business (2021–2026)
Figure 60. Olympus Corporation Revenue Growth Rate in Lung Biopsy Systems Business (2021–2026)
Figure 61. ERBE Elektromedizin GmbH Revenue Growth Rate in Lung Biopsy Systems Business (2021–2026)
Figure 62. Ambu A/S Revenue Growth Rate in Lung Biopsy Systems Business (2021–2026)
Figure 63. Boston Scientific Corporation Revenue Growth Rate in Lung Biopsy Systems Business (2021–2026)
Figure 64. Cook Medical LLC Revenue Growth Rate in Lung Biopsy Systems Business (2021–2026)
Figure 65. KARL STORZ SE & Co. KG Revenue Growth Rate in Lung Biopsy Systems Business (2021–2026)
Figure 66. Technowood Co., Ltd. Revenue Growth Rate in Lung Biopsy Systems Business (2021–2026)
Figure 67. Sumitomo Bakelite Co., Ltd. Revenue Growth Rate in Lung Biopsy Systems Business (2021–2026)
Figure 68. HOYA Corporation (PENTAX Medical) Revenue Growth Rate in Lung Biopsy Systems Business (2021–2026)
Figure 69. FINEMEDIX CO., LTD. Revenue Growth Rate in Lung Biopsy Systems Business (2021–2026)
Figure 70. Upex-Med Corp. Revenue Growth Rate in Lung Biopsy Systems Business (2021–2026)
Figure 71. Medcare Medical (Medcare Medical Co., Ltd.) Revenue Growth Rate in Lung Biopsy Systems Business (2021–2026)
Figure 72. Argon Medical Devices, Inc. Revenue Growth Rate in Lung Biopsy Systems Business (2021–2026)
Figure 73. Becton, Dickinson and Company (BD) Revenue Growth Rate in Lung Biopsy Systems Business (2021–2026)
Figure 74. Hunan Vathin Medical Instrument Co., Ltd. Revenue Growth Rate in Lung Biopsy Systems Business (2021–2026)
Figure 75. Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Revenue Growth Rate in Lung Biopsy Systems Business (2021–2026)
Figure 76. SonoScape Medical Corp. Revenue Growth Rate in Lung Biopsy Systems Business (2021–2026)
Figure 77. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Revenue Growth Rate in Lung Biopsy Systems Business (2021–2026)
Figure 78. Jiangsu Vedkang Medical Science and Technology Co., Ltd. Revenue Growth Rate in Lung Biopsy Systems Business (2021–2026)
Figure 79. Zhuji Peng Tian Medical Instrument Co.,Ltd Revenue Growth Rate in Lung Biopsy Systems Business (2021–2026)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
